However, in the current study, TAC remained relatively unchanged among the treatment groups, suggesting that although GRg3 exhibits antioxidant properties, it may not be sufficient to fully restore the oxidative balance disrupted by Aβ in neuroblastoma cells under the tested conditions. Here, TLE3 is linked to neuroblastoma.